vs

Side-by-side financial comparison of American Healthcare REIT, Inc. (AHR) and Crane NXT, Co. (CXT). Click either name above to swap in a different company.

American Healthcare REIT, Inc. is the larger business by last-quarter revenue ($564.0M vs $476.9M, roughly 1.2× Crane NXT, Co.). Crane NXT, Co. runs the higher net margin — 10.0% vs 1.9%, a 8.0% gap on every dollar of revenue. On growth, Crane NXT, Co. posted the faster year-over-year revenue change (19.5% vs 13.5%). Over the past eight quarters, Crane NXT, Co.'s revenue compounded faster (23.3% CAGR vs 11.7%).

Medical Properties Trust, Inc. (MPT) is an international real estate investment trust (REIT) based in Birmingham, Alabama that purchases and invests in healthcare facilities and for-profit healthcare holding companies, primarily in the United States and Europe. Their property acquisitions often come in the form of sale-leaseback agreements, in which the original property owner sells the property to MPT and becomes their tenant. MPT's tenants are generally subject to long-term triple net lease...

Crane Co. is an American industrial products company based in Stamford, Connecticut. Founded by Richard Teller Crane in 1855, it became one of the leading manufacturers of bathroom fixtures in the United States, until 1990, when that division was sold off. In 1960 it began the process of becoming a holding company with a diverse portfolio. Its business segments are Aerospace & Electronics, Engineered Materials, Fluid Handling, and Controls. Industries served by these segments include chemical...

AHR vs CXT — Head-to-Head

Bigger by revenue
AHR
AHR
1.2× larger
AHR
$564.0M
$476.9M
CXT
Growing faster (revenue YoY)
CXT
CXT
+6.0% gap
CXT
19.5%
13.5%
AHR
Higher net margin
CXT
CXT
8.0% more per $
CXT
10.0%
1.9%
AHR
Faster 2-yr revenue CAGR
CXT
CXT
Annualised
CXT
23.3%
11.7%
AHR

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
AHR
AHR
CXT
CXT
Revenue
$564.0M
$476.9M
Net Profit
$10.8M
$47.5M
Gross Margin
14.8%
42.4%
Operating Margin
19.8%
16.7%
Net Margin
1.9%
10.0%
Revenue YoY
13.5%
19.5%
Net Profit YoY
133.9%
EPS (diluted)
$0.07
$0.82

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
AHR
AHR
CXT
CXT
Q4 25
$564.0M
$476.9M
Q3 25
$532.1M
$445.1M
Q2 25
$501.3M
$404.4M
Q1 25
$497.2M
$330.3M
Q4 24
$496.8M
$399.1M
Q3 24
$476.8M
$403.5M
Q2 24
$458.0M
$370.6M
Q1 24
$452.1M
$313.6M
Net Profit
AHR
AHR
CXT
CXT
Q4 25
$10.8M
$47.5M
Q3 25
$55.9M
$50.5M
Q2 25
$9.9M
$24.9M
Q1 25
$-6.8M
$21.7M
Q4 24
$-31.8M
Q3 24
$-4.1M
$47.1M
Q2 24
$2.0M
$41.6M
Q1 24
$-3.9M
$37.8M
Gross Margin
AHR
AHR
CXT
CXT
Q4 25
14.8%
42.4%
Q3 25
14.6%
43.3%
Q2 25
15.0%
41.7%
Q1 25
13.0%
42.4%
Q4 24
13.3%
45.2%
Q3 24
12.5%
42.5%
Q2 24
12.1%
43.4%
Q1 24
10.7%
48.6%
Operating Margin
AHR
AHR
CXT
CXT
Q4 25
19.8%
16.7%
Q3 25
19.9%
18.4%
Q2 25
20.6%
11.8%
Q1 25
19.0%
11.3%
Q4 24
20.0%
17.7%
Q3 24
19.6%
18.6%
Q2 24
19.4%
18.2%
Q1 24
18.2%
17.7%
Net Margin
AHR
AHR
CXT
CXT
Q4 25
1.9%
10.0%
Q3 25
10.5%
11.3%
Q2 25
2.0%
6.2%
Q1 25
-1.4%
6.6%
Q4 24
-6.4%
Q3 24
-0.9%
11.7%
Q2 24
0.4%
11.2%
Q1 24
-0.9%
12.1%
EPS (diluted)
AHR
AHR
CXT
CXT
Q4 25
$0.07
$0.82
Q3 25
$0.33
$0.87
Q2 25
$0.06
$0.43
Q1 25
$-0.04
$0.38
Q4 24
$-0.23
$1.00
Q3 24
$-0.03
$0.81
Q2 24
$0.01
$0.72
Q1 24
$-0.04
$0.66

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
AHR
AHR
CXT
CXT
Cash + ST InvestmentsLiquidity on hand
$114.8M
$233.8M
Total DebtLower is stronger
$1.0B
Stockholders' EquityBook value
$3.3B
$1.3B
Total Assets
$5.4B
$3.1B
Debt / EquityLower = less leverage
0.80×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
AHR
AHR
CXT
CXT
Q4 25
$114.8M
$233.8M
Q3 25
$147.4M
$182.4M
Q2 25
$133.5M
$152.5M
Q1 25
$86.1M
$173.8M
Q4 24
$76.7M
$165.8M
Q3 24
$67.8M
$165.1M
Q2 24
$52.1M
$175.5M
Q1 24
$77.0M
$220.6M
Total Debt
AHR
AHR
CXT
CXT
Q4 25
$1.0B
Q3 25
$834.3M
Q2 25
$861.8M
Q1 25
$541.1M
Q4 24
$540.6M
Q3 24
$638.2M
Q2 24
$638.9M
Q1 24
$639.6M
Stockholders' Equity
AHR
AHR
CXT
CXT
Q4 25
$3.3B
$1.3B
Q3 25
$2.7B
$1.2B
Q2 25
$2.4B
$1.2B
Q1 25
$2.3B
$1.1B
Q4 24
$2.3B
$1.1B
Q3 24
$2.2B
$1.1B
Q2 24
$1.9B
$989.8M
Q1 24
$2.0B
$964.1M
Total Assets
AHR
AHR
CXT
CXT
Q4 25
$5.4B
$3.1B
Q3 25
$4.8B
$2.9B
Q2 25
$4.5B
$2.9B
Q1 25
$4.5B
$2.4B
Q4 24
$4.5B
$2.4B
Q3 24
$4.7B
$2.4B
Q2 24
$4.6B
$2.4B
Q1 24
$4.7B
$2.1B
Debt / Equity
AHR
AHR
CXT
CXT
Q4 25
0.80×
Q3 25
0.69×
Q2 25
0.73×
Q1 25
0.49×
Q4 24
0.51×
Q3 24
0.60×
Q2 24
0.65×
Q1 24
0.66×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
AHR
AHR
CXT
CXT
Operating Cash FlowLast quarter
$55.2M
$105.8M
Free Cash FlowOCF − Capex
FCF MarginFCF / Revenue
Capex IntensityCapex / Revenue
Cash ConversionOCF / Net Profit
5.12×
2.23×
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
AHR
AHR
CXT
CXT
Q4 25
$55.2M
$105.8M
Q3 25
$107.2M
$92.0M
Q2 25
$71.5M
$62.8M
Q1 25
$60.6M
$-19.1M
Q4 24
$59.5M
$81.1M
Q3 24
$63.1M
$66.7M
Q2 24
$59.4M
$56.8M
Q1 24
$-6.0M
$9.5M
Free Cash Flow
AHR
AHR
CXT
CXT
Q4 25
Q3 25
$78.7M
Q2 25
$55.8M
Q1 25
$-32.2M
Q4 24
Q3 24
$53.5M
Q2 24
$47.9M
Q1 24
$-3.0M
FCF Margin
AHR
AHR
CXT
CXT
Q4 25
Q3 25
17.7%
Q2 25
13.8%
Q1 25
-9.7%
Q4 24
Q3 24
13.3%
Q2 24
12.9%
Q1 24
-1.0%
Capex Intensity
AHR
AHR
CXT
CXT
Q4 25
Q3 25
3.0%
Q2 25
1.7%
Q1 25
4.0%
Q4 24
Q3 24
3.3%
Q2 24
2.4%
Q1 24
4.0%
Cash Conversion
AHR
AHR
CXT
CXT
Q4 25
5.12×
2.23×
Q3 25
1.92×
1.82×
Q2 25
7.21×
2.52×
Q1 25
-0.88×
Q4 24
Q3 24
1.42×
Q2 24
30.02×
1.37×
Q1 24
0.25×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

AHR
AHR

Integrated Senior Health Campuses$467.0M83%
SHOP$97.0M17%

CXT
CXT

Other$260.9M55%
Products$181.1M38%
Services$34.9M7%

Related Comparisons